Stocks

Sight Sciences SGHT

Health care sectorNasdaq

What to see in Sight Sciences now

Is stock about to come to market?$673K

$673K of planned sales filed in 30 days · 0.1% of the units outstanding

Filed 10/01
What comes next?10/12 (Mon)

10/12 estimated earnings

Due 10/12
Is Wall Street adding or cutting?−2

112 13F filers hold it · −2 against the quarter before · shares held −1.6%

Holdings of 06/30

Company

Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Menlo Park, California
Fiscal year end
12/31
Next earnings
10/12, estimated
  • $673K of planned sales filed in 30 days · 0.1% of the units outstandingFiled 10/01

Insider trades

Trade type
Open-market buy06/1006/1114,100 sh$4.88$68,808+1.0%
Alison BauerleinChief Operating Officer
Open-market sale10b5-1 plan05/1805/1912,728 sh$5.12$65,167.36−1.8%
Jeremy B. HaydenChief Legal Officer
Open-market sale10b5-1 plan04/0604/0913,761 sh$3.55$48,851.55−3.6%
James RodbergChief Financial Officer
Open-market sale10b5-1 plan04/0604/097,231 sh$3.55$25,670.05−3.0%
David BadawiChief Technology Officer
Open-market sale10b5-1 plan04/0204/038,168 sh$3.48$28,424.64−0.4%
All insider trades in Sight Sciences

Planned sales

Badawi PaulOfficer, Director
Sight SciencesSGHT
29,653 sh$268,332.9610/01Filed 10/01
Badawi DavidOfficer, Director
Sight SciencesSGHT
7,797 sh$70,555.8410/01Filed 10/01
Hayden Jeremy B.Former Officer
Sight SciencesSGHT
2,746 sh$24,768.9210/01Filed 10/01
Hayden Jeremy B.Former Officer
Sight SciencesSGHT
22,254 sh$208,051.6509/30Filed 09/30
Hayden Jeremy B.Former Officer
Sight SciencesSGHT
12,219 sh$101,265.7409/04Filed 09/04
Hayden Jeremy B.Former Officer
Sight SciencesSGHT
13,253 sh$109,974.7209/01Filed 09/01
Hayden Jeremy B.Former Officer
Sight SciencesSGHT
12,014 sh$97,841.4808/17Filed 08/17
Hayden Jeremy B.Former Officer
Sight SciencesSGHT
48,000 sh$395,878.8408/14Filed 08/14
Hayden Jeremy B.Former Officer
Sight SciencesSGHT
2,500 sh$20,762.508/13Filed 08/13
Hayden Jeremy B.Former Officer
Sight SciencesSGHT
16,302 sh$133,307.0908/12Filed 08/12
All planned sales of Sight Sciences

26-week trading